1. Introduction
===============

Inflammation has been studied for thousands of years. Celsius (in 30 A.D.) described the four classical signs of inflammation (redness, heat, pain, and swelling), and used willow leaf extracts to relieve them \[[@B1-molecules-16-08515]\].

The inflammatory process is a reaction of the body to the penetration of an infectious agent, an antigen, or cell damage. Inflammation is the most frequent sign of disease, and is also a fundamental biological process involving complex pathways that are often induced by the products of bacterial degradation from various microorganisms; lipopeptides, lipopolysaccharides, peptidoglycans, formylmethionyl peptides, flagellin, microbial DNA), fungi (zymosans), viruses (double-stranded RNA), or even the body's own cells upon damage and death \[[@B2-molecules-16-08515]\].

The inflammatory response starts with signal recognition that may have an infectious or inflammatory origin, and the release of chemicals from tissues and migrating cells called mediators \[[@B3-molecules-16-08515]\]. The list of these mediators includes amines like histamine and 5-hydroxytryptamine, bradykinin, (representing short peptides), long peptides such as interleukin-1 (IL-1), lipids such as prostaglandins (PGs) and leukotrienes (LTs), and enzymes \[[@B1-molecules-16-08515]\]. During the immune response, these mediators recruit adjacent cells through the paracrinal process. When these mediators exceed local borders, they disseminate, and distribute through the blood, producing endocrinal generalized cellular activation, or systematic inflammatory response syndrome (SIRS). SIRS is a host defense mechanism, and part of the tissue repair process. To effectively initiate this defense mechanism, cytokines with pro-inflammatory function are required, such as TNF-α, IL-1β, interleukin-12 (IL-12), interferon-γ (IFN-γ) and possibly IL-6 \[[@B4-molecules-16-08515],[@B5-molecules-16-08515],[@B6-molecules-16-08515],[@B7-molecules-16-08515]\]. The initial inflammatory response is controlled by immune-regulating molecules through specific inhibitors, and soluble cytokine receptors. The main anti-inflammatory cytokines are transforming beta growth factor (TGF-β) and interleukins 4 and 10. Specific receptors for IL-1, TNF-α and interleukin-18 (IL-18) act as inhibitors of their own pro-inflammatory cytokines. Under physiological conditions immune-modulator molecules act to limit the potentially harmful effects of the inflammatory response \[[@B3-molecules-16-08515]\]. The importance of each of these mediators can be seen when it is removed (either by preventing its generation with enzyme inhibitors or by preventing its pharmacological effects with selective antagonists) \[[@B1-molecules-16-08515]\].

In inflammation research, several experimental models have been used to evaluate inflammation. The usual method of determining whether compounds have anti-inflammatory activity is to test them in animal, and biochemical inflammation models. However there is no single experimental model that covers all aspects of inflammation.

Natural products have long been recognized as an important source of therapeutically effective medicines. It is recognized that natural-product structures have great chemical diversity, biochemical specificity, and other molecular properties that make them favorable lead structures \[[@B8-molecules-16-08515],[@B9-molecules-16-08515],[@B10-molecules-16-08515],[@B11-molecules-16-08515],[@B12-molecules-16-08515],[@B13-molecules-16-08515]\].

Among the 877 small-molecules New Chemical Entities (NCEs) introduced between 1981 and 2002, roughly 49% (\~429 molecules) were natural products, semi-synthetic natural product analogues, or synthetic compounds based on natural-products \[[@B9-molecules-16-08515]\], moreover, between 2005 and 2007, 13 natural, product-derived drugs were approved in the United States, with five of them being the first members of new classes \[[@B14-molecules-16-08515]\]. In recent years advances in chemical and pharmacological techniques have contributed to the knowledge of new therapeutically active compounds obtained from natural products \[[@B15-molecules-16-08515]\].

The alkaloids represent the largest single class of plant secondary metabolites. They have a remarkable range of often dramatic pharmacological activity, and are also often toxic to man \[[@B16-molecules-16-08515]\]. Many alkaloids are used in therapeutics and as pharmacological tools. A wide range of biological effects has been reported for alkaloids, including emetic, anti-cholinergic, antitumor, diuretic, sympatho-mimetic, antiviral, antihypertensive, hypno-analgesic, antidepressant, mio-relaxant, anti-tussigen, antimicrobial and anti-inflammatory activities \[[@B17-molecules-16-08515],[@B18-molecules-16-08515],[@B19-molecules-16-08515]\]. However, alkaloids and other natural compounds are generally complex, making it necessary to analyze their pharmacological activities using several experimental methods and demonstrate their structure/activity correlation. It is common to find pharmacological data where a single experimental model was used to demonstrate a biological activity. However pathological responses are extremely complex involving many biological events, so it is necessary to use different experimental models to define the exactly mechanism of action of the analyzed molecule \[[@B20-molecules-16-08515]\].

In the course of our continuing search for bioactive natural plant products, we have published reviews on crude plant extracts and plant-derived compounds with potential uses \[[@B21-molecules-16-08515],[@B22-molecules-16-08515],[@B23-molecules-16-08515],[@B24-molecules-16-08515],[@B25-molecules-16-08515],[@B26-molecules-16-08515],[@B27-molecules-16-08515],[@B28-molecules-16-08515],[@B29-molecules-16-08515],[@B30-molecules-16-08515],[@B31-molecules-16-08515],[@B32-molecules-16-08515],[@B33-molecules-16-08515],[@B34-molecules-16-08515],[@B35-molecules-16-08515],[@B36-molecules-16-08515],[@B37-molecules-16-08515]\]. Moreover, our group has also reviewed the medicinal and poisonous plants of Northeast Brazil \[[@B38-molecules-16-08515],[@B39-molecules-16-08515]\], among others \[[@B40-molecules-16-08515],[@B41-molecules-16-08515],[@B42-molecules-16-08515],[@B43-molecules-16-08515],[@B44-molecules-16-08515],[@B45-molecules-16-08515],[@B46-molecules-16-08515],[@B47-molecules-16-08515],[@B48-molecules-16-08515],[@B49-molecules-16-08515],[@B50-molecules-16-08515],[@B51-molecules-16-08515],[@B52-molecules-16-08515]\]. Recently we published a review on the anti-inflammatory activity of alkaloids reported in the twentieth century, more precisely covering the period from 1907 to 2000 \[[@B53-molecules-16-08515]\]. Now we present an update of the literature on alkaloids with anti-inflammatory activity from 2000 to 2010. The search was carried out on data banks such as Web of Science, Chemical Abstracts, and NAPRALERT (acronym for the University of Illinois Natural Products ALERT service). The references found in the searches were later consulted. For details on the mechanism-based bioassays utilized for anti-inflammatory activity, the original references should be consulted.

2. Results and Discussion
=========================

Isoquinoline, quinoline and indole alkaloids were the most studied classes for anti-inflammatory activity. Among the isoquinolines, berberine was the most studied compound, being active in almost all the experimental models described in [Table 1](#molecules-16-08515-t001){ref-type="table"}. This compound is present in numerous plants of the *Berberis* and *Coptis* genera \[[@B54-molecules-16-08515]\]. It is one of the major components of *Coptis chinesis*, which is frequently utilized in Chinese herbal drugs to treat inflammatory reactions. Berberine has a variety of pharmacologic effects, including inhibition of TPA-induced mouse ear edema, indicating that this alkaloid may have activity against chronic inflammation \[[@B55-molecules-16-08515]\].

Investigations demonstrated that warifteine, a bisbenzylisoquinoline alkaloid isolated from *Cissampelos sympodialis*, inhibits eosinophil recruitment, eotaxin and cisteinyl leukotriene production in the pleural cavities, and lungs of allergic mice, as well as inhibiting in the production of nitric oxide mediators. These data highlight the role of warifteine as a potential anti-allergic and anti-inflammatory molecule \[[@B56-molecules-16-08515],[@B57-molecules-16-08515]\]. Other isoquinoline alkaloids like berbamine, palmatine and columbamine were also examined demonstrating significant dose-dependent inhibitory activity in serotonin-induced hind paw edema assays for both oral and topical applications, and in oral administration, on acetic acid-induced vascular permeability \[[@B58-molecules-16-08515]\].

The quinolizidine alkaloids matrine and oxymatrine, isolated from *Sophora subprostrata* (a Chinese plant used as an antipyretic, antidote, and analgesic) exhibited *in vitro* cyclooxygenase inhibition and antioxidant activity, providing scientific support for their existing medicinal use in traditional Chinese medicine \[[@B59-molecules-16-08515]\].

Indole alkaloids such as brucine and brucine-N-oxide were also reported in this review. They demonstrated significant analgesic and anti-inflammatory properties. Both compounds demonstrated a substantial protective effect in experimental models such as hot-plate test and writhing test. Although, in formalin test, they exhibited their analgesic activity in different phases. In carrageenan-induced rat paw edema experiment, brucine *N*-oxide showed stronger inhibitory effect than brucine. In addition, these two substances have diminished acetic-acid induced vascular permeability and inhibited the release of PGE~2~ in inflammatory tissue. These results suggest that brucine and brucine-*N*-oxide have different biochemical mechanisms, in spite of having similar chemical structure \[[@B60-molecules-16-08515]\].

Marine natural products have been the focus for discovery of new chemical and pharmacological products. A bisindolic alkaloid named caulerpin isolated from the lipoid extract of the algae *Caulerpa racemosa* exhibited anti-inflammatory activity in mice when given orally at a concentration of 100 μmol/kg \[[@B63-molecules-16-08515]\]. The bisindolic pharmacophoric nucleus of caulerpin is most likely responsible for the wide variety of biological properties tested; anti-inflammatory, antinociceptive \[[@B61-molecules-16-08515]\] insecticidal \[[@B62-molecules-16-08515]\], tumor inhibition \[[@B63-molecules-16-08515]\], and inhibition of hypoxia transcription factor \[[@B64-molecules-16-08515]\], all for this one alkaloid.

Amide alkaloids such as riparin I (*N*-benzoyl tyramine) and II (*N*-(2-hydroxybenzoyl) tyramine), isolated from the unripe fruit of *Aniba riparia* decreased carrageenan-induced paw edema at 4 h and 2 h respectively, when compared to a control \[[@B65-molecules-16-08515],[@B66-molecules-16-08515]\]. It appears that the degree of hydroxylation of the benzoyl moiety increases the anti-inflammatory activity.

Most of the alkaloids reported in this review offer considerable promise as anti-inflammatory compounds or drug candidates and some of them appear to be remarkably active. The results of this search are presented in [Table 1](#molecules-16-08515-t001){ref-type="table"} in alphabetical order of their chemical names, followed by the plant species of origin. The references were consulted for details of the experimental models used while testing the alkaloid's anti-inflammation activities (assay, organism tested, dose or concentration, activity, and references).

molecules-16-08515-t001_Table 1

###### 

Alkaloids with anti-inflammatory activity.

  Substance and (Source)                                                                                           Assay                                                                                                  Organism tested                       Dose                           Activity                        Ref.
  ---------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------ ------------------------------------- ------------------------------ ------------------------------- -------------------------------
  ![](molecules-16-08515-i001.jpg)                                                                                 *In vivo*, 5-HT-Induced pedal edema                                                                    Mouse                                 200 mg/Kg                      Inactive                        \[[@B58-molecules-16-08515]\]
  *In vivo*, 5-HT-Induced pedal edema                                                                              Mouse                                                                                                  200 mg/Kg                             Active                         \[[@B58-molecules-16-08515]\]   
  ![](molecules-16-08515-i002.jpg)                                                                                 *In vivo*, inhibitory activity on superoxide generation by human neutrophils                           Human                                 IC~50~ ≤ 5.34 µg/mL            Active                          \[[@B67-molecules-16-08515]\]
  *In vivo*, inhibitory activity on elastase release by human neutrophils                                          Human                                                                                                  IC~50~ ≤ 5.53 µg/mL                   Active                         \[[@B67-molecules-16-08515]\]   
  ![](molecules-16-08515-i003.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Rat                                   1 mg/Kg                        Active                          \[[@B68-molecules-16-08515]\]
  ![](molecules-16-08515-i004.jpg)                                                                                 *In vivo*, inhibitory activity on superoxide generation by human neutrophils                           Human                                 IC~50~ ≤ 5.34 µg/mL            Active                          \[[@B67-molecules-16-08515]\]
  ![](molecules-16-08515-i005.jpg)                                                                                 *In vivo*, 5-HT-induced pedal edema                                                                    Mouse                                 200 mg/Kg                      Active                          \[[@B58-molecules-16-08515]\]
  *In vivo*, 5-HT-induced pedal edema                                                                              Mouse                                                                                                  100 mg/Kg                             Active                         \[[@B58-molecules-16-08515]\]   
                                                                                                                   *In vivo*, TNB-induced colitis                                                                         Rat                                   15 mg/Kg                       Active                          \[[@B69-molecules-16-08515]\]
  ![](molecules-16-08515-i006.jpg)                                                                                 *In vivo*, LPS-induced hepatoxicity                                                                    Mouse                                 100 mg/Kg                      Inactive                        \[[@B70-molecules-16-08515]\]
  *In vivo*, carrageenan-induced pedal edema                                                                       Mouse                                                                                                  2 mg/Kg                               Active                         \[[@B70-molecules-16-08515]\]   
                                                                                                                   *In vivo*, LPS-induced hepatoxicity                                                                    Mouse                                 209 mg/Kg                      Active                          \[[@B70-molecules-16-08515]\]
  *In vivo*, 5-HT induced-pedal edema                                                                              Mouse                                                                                                  200 mg/Kg                             Active                         \[[@B58-molecules-16-08515]\]   
  *In vivo*, Carrageenan-induced pedal edema                                                                       Rat                                                                                                    5 mg/Kg                               Active                         \[[@B55-molecules-16-08515]\]   
  *In vivo*, acute inflammation induced by *E. coli* LPS                                                           Chicken                                                                                                15 mg/Kg                              Active                         \[[@B71-molecules-16-08515]\]   
  ![](molecules-16-08515-i007.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Rat                                   15 mg/Kg                       Active                          \[[@B60-molecules-16-08515]\]
  ![](molecules-16-08515-i008.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Rat                                   100 mg/Kg                      Active                          \[[@B60-molecules-16-08515]\]
  ![](molecules-16-08515-i009.jpg)                                                                                 *In vivo*, capsaicin-induced ear edema                                                                 Mouse                                 100 µmol/Kg                    Active                          \[[@B61-molecules-16-08515]\]
  ![](molecules-16-08515-i010.jpg)                                                                                 In humans, oral                                                                                        Human adult                           0.5 mg/person                  Active                          \[[@B72-molecules-16-08515]\]
  ![](molecules-16-08515-i011.jpg)                                                                                 *In vivo*, External, 5-HT-induced pedal edema                                                          Mouse                                 200 mg/Kg                      Inactive                        \[[@B58-molecules-16-08515]\]
  *In vivo*, Intragastric, 5-HT-induced pedal edema                                                                Mouse                                                                                                  200 mg/Kg                             Inactive                       \[[@B58-molecules-16-08515]\]   
  ![](molecules-16-08515-i012.jpg)                                                                                 *In vivo*, inhibitory activity on superoxide generation by human neutrophils                           Human                                 IC~50~ ≤ 5.34 µg/mL            Active                          \[[@B67-molecules-16-08515]\]
  *In vivo*, inhibitory activity on elastase release by human neutrophils                                          Human                                                                                                  IC~50~ ≤ 5.53 µg/mL                   Active                         \[[@B67-molecules-16-08515]\]   
  ![](molecules-16-08515-i013.jpg)                                                                                 *In vivo*, carrageenan-induced paw edema                                                               Rat                                   10 mg/Kg                       Active                          \[[@B73-molecules-16-08515]\]
  ![](molecules-16-08515-i014.jpg)                                                                                 *In vivo*, carrageenan-induced rat paw edema                                                           Rat                                   20 mg/Kg                       Active                          \[[@B74-molecules-16-08515]\]
  ![](molecules-16-08515-i015.jpg)                                                                                 *In vivo*, croton oil-induced edema                                                                    Mouse                                 20 mg/Kg                       Active                          \[[@B75-molecules-16-08515]\]
  *In vivo*, croton oil-induced edema                                                                              Mouse                                                                                                  0.1 mg/Kg                             Active                         \[[@B75-molecules-16-08515]\]   
  *In vitro*, fMLP-induced neutrophil adhesion and transmigration                                                  Human                                                                                                  10 µg/mL                              Active                         \[[@B76-molecules-16-08515]\]   
  ![](molecules-16-08515-i016.jpg)                                                                                 *In vivo*, croton oil-induced ear edema                                                                Mouse                                 4.2 ± 0.5 mg/Kg                Active                          \[[@B77-molecules-16-08515]\]
  ![](molecules-16-08515-i017.jpg)                                                                                 *In vivo*, croton oil-induced ear edema                                                                Mouse                                 3.7 ± 0.8 mg/Kg                Active                          \[[@B77-molecules-16-08515]\]
  ![](molecules-16-08515-i018.jpg)                                                                                 *In vitro*, inhibitory activity on superoxide anion generation                                         Human                                 IC~50~ \< 5.5 5.43±1.52µg/mL   Active                          \[[@B78-molecules-16-08515]\]
  *In vitro*, inhibitory activity on elastase release by human neutrophils                                         Human                                                                                                  IC~50~ \< 5.5 3.25 ± 0.31 µg/mL       Active                         \[[@B78-molecules-16-08515]\]   
  ![](molecules-16-08515-i019.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Mouse                                 1 mg/Kg                        Active                          \[[@B79-molecules-16-08515]\]
  ![](molecules-16-08515-i020.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Mouse                                 1 mg/Kg                        Active                          \[[@B79-molecules-16-08515]\]
  ![](molecules-16-08515-i021.jpg)                                                                                 \*                                                                                                     \*                                    \*                             Inactive                        \[[@B80-molecules-16-08515]\]
  ![](molecules-16-08515-i022.jpg)                                                                                 *In vitro*, macrophages                                                                                Human adult                           400 mg/L                       Active                          \[[@B81-molecules-16-08515]\]
  *In vivo*, carrageenan-induced pedal edema                                                                       Rat                                                                                                    50 mg/Kg                              Active                         \[[@B82-molecules-16-08515]\]   
  *In vivo*, Cotton pellet granuloma                                                                               Mouse                                                                                                  50 mg/Kg                              Active                         \[[@B82-molecules-16-08515]\]   
  ![](molecules-16-08515-i023.jpg)                                                                                 *In vivo*, 5-HT-induced pedal edema                                                                    Mouse                                 200 mg/Kg                      Inactive                        \[[@B58-molecules-16-08515]\]
  *In vivo*, 5-HT-induced pedal edema                                                                              Mouse                                                                                                  200 mg/Kg                             Inactive                       \[[@B58-molecules-16-08515]\]   
  ![](molecules-16-08515-i024.jpg)                                                                                 \*                                                                                                     \*                                    \*                             Inactive                        \[[@B80-molecules-16-08515]\]
  ![](molecules-16-08515-i025.jpg)                                                                                 \*                                                                                                     \*                                    \*                             Inactive                        \[[@B80-molecules-16-08515]\]
  ![](molecules-16-08515-i026.jpg)                                                                                 *In vitro*, inhibitory activity of COX-1                                                               Rat                                   31.3 µM                        Active                          \[[@B59-molecules-16-08515]\]
  *In vitro*, inhibitory activity of COX-2                                                                         Rat                                                                                                    188.5 µM                              Moderate activity              \[[@B59-molecules-16-08515]\]   
  ![](molecules-16-08515-i027.jpg)                                                                                 *In vitro*, inhibitory activity of COX-1                                                               Rat                                   197.8 µM                       Moderate activity               \[[@B59-molecules-16-08515]\]
  *In vitro*, inhibitory activity of COX-2                                                                         Rat                                                                                                    385.1 µM                              Weak activity                  \[[@B59-molecules-16-08515]\]   
  ![](molecules-16-08515-i028.jpg)                                                                                 *In vivo*, collagen II -induced arthritis                                                              Mouse                                 10 mg/Kg                       Active                          \[[@B83-molecules-16-08515]\]
  ![](molecules-16-08515-i029.jpg)                                                                                 *In vivo*, 5-HT-induced pedal edema                                                                    Mouse                                 200 mg/Kg                      Inactive                        \[[@B58-molecules-16-08515]\]
  *In vivo*, 5-HT-induced pedal edema                                                                              Mouse                                                                                                  100 mg/Kg                             Active                         \[[@B58-molecules-16-08515]\]   
  ![](molecules-16-08515-i030.jpg)                                                                                 *In vitro*, inhibitory activity on NO production                                                       Rat                                   40 µg/mL                       Active                          \[[@B84-molecules-16-08515]\]
  *In vitro*, inhibitory activity on PGE~2~ production                                                             Rat                                                                                                    40 µg/mL                              Active                         \[[@B84-molecules-16-08515]\]   
  ![](molecules-16-08515-i031.jpg)                                                                                 *In vitro*, inhibitory activity on COX-1                                                               \*                                    100 µM                         Inactive                        \[[@B85-molecules-16-08515]\]
  *In vitro*, inhibitory activity on COX-2                                                                         \*                                                                                                     100 µM                                Weak activity                  \[[@B85-molecules-16-08515]\]   
  *In vitro*, inhibitory activity on 5-LOX                                                                         \*                                                                                                     100 µM                                Active                         \[[@B85-molecules-16-08515]\]   
  *In vivo*, carrageenan-induced air pouch formation                                                               Mouse                                                                                                  10 mg/Kg                              Active                         \[[@B85-molecules-16-08515]\]   
  *In vivo*, xylene-induced ear edema                                                                              Mouse                                                                                                  10 mg/Kg                              Active                         \[[@B85-molecules-16-08515]\]   
  ![](molecules-16-08515-i032.jpg)                                                                                 *In vivo*, intragastric                                                                                Rat                                   20 mg/Kg                       Active                          \[[@B86-molecules-16-08515]\]
  ![](molecules-16-08515-i033.jpg)                                                                                 In humans, oral                                                                                        Human adult                           200 mg/day                     Inactive                        \[[@B87-molecules-16-08515]\]
  ![](molecules-16-08515-i034.jpg)                                                                                 *In vivo*, formalin test                                                                               Mice                                  25 mg/Kg                       Active                          \[[@B88-molecules-16-08515]\]
  *In vivo*, carrageenan-induced pedal edema                                                                       Mice                                                                                                   25 mg/Kg                              Active                         \[[@B65-molecules-16-08515]\]   
  ![](molecules-16-08515-i035.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Rat                                   25 mg/Kg                       Active                          \[[@B66-molecules-16-08515]\]
  ![](molecules-16-08515-i036.jpg)                                                                                 *In vitro*, inhibitory activity on COX-1                                                               Mice                                  100 µM                         Active                          \[[@B85-molecules-16-08515]\]
  *In vitro*, inhibitory activity on COX-2                                                                         Mice                                                                                                   100 µM                                Active                         \[[@B85-molecules-16-08515]\]   
  *In vitro*, inhibitory activity on 5-LOX                                                                         Mice                                                                                                   100 µM                                Active                         \[[@B85-molecules-16-08515]\]   
  *In vivo*, carrageenan-induced air pouch formation                                                               Mouse                                                                                                  5 mg/Kg                               Active                         \[[@B85-molecules-16-08515]\]   
  *In vivo*, xylene-induced ear edema                                                                              Mouse                                                                                                  5 mg/Kg                               Active                         \[[@B85-molecules-16-08515]\]   
  ![](molecules-16-08515-i037.jpg)                                                                                 *In vitro*, phorbol-induced edema of the mouse ear                                                     Mouse                                 5--100 µg/ear                  Active                          \[[@B89-molecules-16-08515]\]
  ![](molecules-16-08515-i038.jpg)                                                                                 *In vivo*, collagen II induced arthritis                                                               Rat                                   3.036 mg/Kg                    Active                          \[[@B90-molecules-16-08515]\]
  ![](molecules-16-08515-i039.jpg)                                                                                 *In vivo*, TPA-induced inflammation                                                                    Mouse                                 0.75 mg/ear                    Active                          \[[@B91-molecules-16-08515]\]
  ![](molecules-16-08515-i040.jpg)                                                                                 *In vivo*, carrageenan-induced pedal edema                                                             Rat                                   \*                             Inactive                        \[[@B92-molecules-16-08515]\]
  *In vivo*, cotton pellet granuloma                                                                               Rat                                                                                                    \*                                    Inactive                       \[[@B92-molecules-16-08515]\]   
  ![](molecules-16-08515-i041.jpg)                                                                                 *In vitro*, colorimetric assay with tetrazolium salt                                                   Blood drawn from healthy volunteers   100 µg/mL                      Weak Activity                   \[[@B93-molecules-16-08515]\]
  ![](molecules-16-08515-i042.jpg)                                                                                 *In vivo*, croton oil-induced edema                                                                    Mouse                                 20 mg/Kg                       Active                          \[[@B75-molecules-16-08515]\]
  *In vivo*, croton oil-induced edema                                                                              Mouse                                                                                                  0.1 mg/Kg                             Active                         \[[@B75-molecules-16-08515]\]   
  *In vitro*, FMLP-induced neutrophil adhesion and transmigration                                                  Human                                                                                                  10 µg/mL                              Active                         \[[@B76-molecules-16-08515]\]   
  ![](molecules-16-08515-i043.jpg)                                                                                 *In vivo*, xylene-induced ear edema                                                                    Mouse                                 8 mg/Kg                        Active                          \[[@B94-molecules-16-08515]\]
  *In vivo*, acetic acid-induced vascular permeability                                                             Mouse                                                                                                  16 mg/Kg                              Active                         \[[@B94-molecules-16-08515]\]   
  *In vivo*, carrageenan-induced paw edema                                                                         Mouse                                                                                                  8 mg/Kg                               Active                         \[[@B94-molecules-16-08515]\]   
  ![](molecules-16-08515-i044.jpg)                                                                                 *In vitro*, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay system   Human                                 IC~50~ = 27.3 µg/mL            Weak activity                   \[[@B95-molecules-16-08515]\]
  ![](molecules-16-08515-i045.jpg)                                                                                 *In vitro*, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay system   Human                                 IC~50~ = 48.3 µg/mL            Weak activity                   \[[@B95-molecules-16-08515]\]
  ![](molecules-16-08515-i046.jpg)                                                                                 *In vitro*, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay system   Human                                 IC~50~ = 4.21 µg/mL            Active                          \[[@B95-molecules-16-08515]\]
  ![](molecules-16-08515-i047.jpg)                                                                                 *In vitro*, zymosan activated human polymorphonuclear leucocytes in a chemoluminescence assay system   Human                                 IC~50~ = 79.1 µg/mL            Weak activity                   \[[@B95-molecules-16-08515]\]
  ![](molecules-16-08515-i048.jpg)                                                                                 *In vitro*, inhibitory activity on COX-1                                                               Mice                                  100 µM                         Active                          \[[@B85-molecules-16-08515]\]
  *In vitro*, inhibitory activity on COX-2                                                                         Mice                                                                                                   100 µM                                Active                         \[[@B85-molecules-16-08515]\]   
  *In vitro*, inhibitory activity on 5-LOX                                                                         Mice                                                                                                   100 µM                                Active                         \[[@B85-molecules-16-08515]\]   
  *In vivo*, carrageenan-induced air pouch formation                                                               Mouse                                                                                                  8 mg/Kg                               Active                         \[[@B85-molecules-16-08515]\]   
  *In vivo*, xylene-induced ear edema                                                                              Mouse                                                                                                  8 mg/Kg                               Active                         \[[@B85-molecules-16-08515]\]   
  ![](molecules-16-08515-i049.jpg)                                                                                 *In vivo*, allergic eosinophilia and cysteinyl leukotrienes production                                 Mice                                  50 μg/animal                   Active                          \[[@B56-molecules-16-08515]\]
  *In vitro*. OVA-sensitized animals were evaluated. The response was related with the increase of NO production   Mice                                                                                                   0.4--10 mg/Kg                         Active                         \[[@B57-molecules-16-08515]\]   

\* Data incomplete, derived from an abstract.

3. Conclusions
==============

Of the 49 alkaloids evaluated, 40, among which the isoquinolines figured most prominently, demonstrated anti-inflammatory activity. Carrageenan-induced pedal edema was the most utilized experimental model for evaluating anti-inflammatory activity. In this review, 95 references were cited.
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